Yeah TLX592 seems OK in that respect though.
Early days but from their proof of concept study recently released;
Initial results demonstrate rapid elimination from blood circulation compared to standard antibodies and hepatic (liver) clearance – both highly desirable characteristics for use with alpha emitting agents.
Yeah TLX592 seems OK in that respect though.Early days but from...
-
- There are more pages in this discussion • 230 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.28 |
Change
0.055(0.88%) |
Mkt cap ! $1.981B | |||
| Open | High | Low | Value | Volume |
| $6.29 | $6.30 | $6.25 | $1.344M | 213.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 2232 | $6.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.28 | 1791 | 5 |
View Market Depth
| Last trade - 11.40am 15/08/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |